NCT00262028View on ClinicalTrials.gov

Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Children

PHASE2CompletedINTERVENTIONAL

Enrollment

910

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions

Prevention of Meningococcal Disease

Interventions

BIOLOGICAL

MenACWY-CRM Vaccine

BIOLOGICAL

MenACWY-PS Vaccine

Trial Locations (1)

94612

Kaiser Permanente Vaccine Study Center, Oakland

Sponsors

Lead Sponsor

Novartis Vaccines

All Listed Sponsors

lead

Novartis Vaccines

INDUSTRY